Somalogic
SomaLogic Inc SomaLogic is a protein biomarker discovery and somalogic diagnostics company, somalogic. Somalogic provides SOMAscan assay, a proteomics technology that compares protein levels in individuals with and without various health conditions and identify biological signals of proteins to develop predictive state tests for disease, health and wellness. It also offers its SOMAscan technology available to healthcare researchers for conducting clinical protein measurements and biomarker discovery. A database of medical devices that are in the process to get approved for sale around the world, somalogic.
Measure high- and low-abundance proteins confidently with superior sensitivity, high specificity, and proven reproducibility. See the science. Explore our services. Find out. Learn more about the benefit of low CVs. Get broad, deep coverage — half the human proteome — in a number of therapeutic areas on a scalable platform. Read the paper.
Somalogic
Nasdaq: LAB , driven by a bold purpose — Unleashing tools to accelerate breakthroughs in human health , today announced that it has completed its merger with SomaLogic, creating a leading provider of differentiated multi-omics tools for research. Each SomaLogic stockholder will receive 1. As a larger well-capitalized company, we have greater capacity to self-fund future growth initiatives and accelerate research insights across the industry, better serving our customers and delivering sustainable long-term growth for our shareholders. We are focused on ensuring a smooth transition and achieving our stated commitments. The combined company is poised to realize significant benefits as a multi-omic technology leader, targeting large, high growth markets with a diverse portfolio of life sciences tools that power industry-leading throughput and data quality. The combined company is moving forward focused on:. Expanding its commercial reach and maximizing cross-selling opportunities through complementary offerings and end markets. Delivering additional meaningful value creation opportunities through a proven model that couples deep large-enterprise life sciences expertise and operating discipline. Carey has been appointed as Chairman of the Board. Standard BioTools Inc. Nasdaq:LAB , previously known as Fluidigm Corporation, is driven by a bold purpose — Unleashing tools to accelerate breakthroughs in human health. Standard BioTools has an established portfolio of essential, standardized next-generation technologies that help biomedical researchers develop medicines faster and better. As a leading solutions provider, the company provides reliable and repeatable insights in health and disease using its proprietary mass cytometry and microfluidics technologies, which help transform scientific discoveries into better patient outcomes. Standard BioTools works with leading academic, government, pharmaceutical, biotechnology, plant and animal research, and clinical laboratories worldwide, focusing on the most pressing needs in translational and clinical research, including oncology, immunology, and immunotherapy. Learn more at www.
ProViz is a basic data visualization and analysis tool developed at Somalogic.
While the two systems are based on different technologies, both of which have advantages and drawbacks versus the other, users and industry observers broadly agreed that the divergence in their paths has largely been driven by past business decisions rather than the performance of their platforms. SomaLogic was the first to tackle this market. More than a decade ago, the company was offering an early version of SomaScan that measured roughly 1, proteins. It upped that to 5, proteins in and expanded it to 7, in Olink, meanwhile, did not enter the high-plex market until June when it launched its Explore assay , which measured roughly 1, proteins in plasma or serum. This year, the company launched its Explore HT platform , which measures more than 5, proteins. Yet, despite its multiyear head start and significantly larger assay multiplex, SomaLogic has substantially underperformed Olink in terms of both sales and market valuation.
Measure high- and low-abundance proteins confidently with superior sensitivity, high specificity, and proven reproducibility. See the science. Explore our services. Find out. Learn more about the benefit of low CVs. Get broad, deep coverage — half the human proteome — in a number of therapeutic areas on a scalable platform.
Somalogic
The SomaScan Platform is a high-plex , high-throughput proteomics technology developed by SomaLogic that revolutionizes how researchers gain insights into protein biology and protein-protein interactions. As a single solution for discovery, validation, and development, the SomaScan Platform is pioneering proteomics. The platform:. Go in-depth on how the SomaScan Assay works.
Oneiu
He added that this has hampered SomaLogic's ability to win contracts with large biobank organizations and population health studies, which have emerged as major customers for high-plex proteomic platforms. Read Edit View history. All other trademarks are the sole property of their respective owners. ISBN An Illumina-based readout won't be exclusive to SomaLogic. Top languages R Python. Daily Camera Boulder. You signed in with another tab or window. A kit-based SomaScan will make for easier customer access as well as higher margins, Taich said, projecting that the kits will have 60 percent-plus gross margins, roughly 10 points higher than the margins for the company's services business. It also signed a development deal with Quest Diagnostics to create a blood test for early-stage, non-small-cell lung cancer. Bitcoin USD 62,
The field of proteomics is rapidly expanding as technology evolves to analyze protein dynamics, adding to the vast knowledge of DNA and RNA by providing new biological insights and discoveries.
These forward-looking statements speak only as of the date hereof. Nature Medicine. Get a high-throughput, multiplex proteomics solution that focuses on the complexity of neurological diseases. More than a decade ago, the company was offering an early version of SomaScan that measured roughly 1, proteins. Find out. Graphics types are biased towards vis…. Learn how you can gain new biological insights into the human proteome and the complex molecular interactions of human health and disease with the SomaLogic solutions listed below. The package provides auxiliary functions for extracting relevant information from the ADAT object once in the Python environment. Last updated Name Stars. Industry Medical Equipment. Rare disease Advancing rare disease research with powerful protein profiling and offering new insights into biomarker discovery.
Willingly I accept. An interesting theme, I will take part. Together we can come to a right answer.
Quite right! It is good thought. I call for active discussion.
I consider, that you commit an error.